PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs

Detalles Bibliográficos
Autores principales: Vatta, P, Taddio, A, Lepore, L, Moressa, V, Naviglio, S, Prinzi, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044208/
http://dx.doi.org/10.1186/1546-0096-11-S2-P100
_version_ 1782319105694498816
author Vatta, P
Taddio, A
Lepore, L
Moressa, V
Naviglio, S
Prinzi, E
author_facet Vatta, P
Taddio, A
Lepore, L
Moressa, V
Naviglio, S
Prinzi, E
author_sort Vatta, P
collection PubMed
description
format Online
Article
Text
id pubmed-4044208
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40442082014-06-17 PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs Vatta, P Taddio, A Lepore, L Moressa, V Naviglio, S Prinzi, E Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044208/ http://dx.doi.org/10.1186/1546-0096-11-S2-P100 Text en Copyright © 2013 Vatta et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Vatta, P
Taddio, A
Lepore, L
Moressa, V
Naviglio, S
Prinzi, E
PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs
title PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs
title_full PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs
title_fullStr PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs
title_full_unstemmed PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs
title_short PReS-FINAL-2088: Risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs
title_sort pres-final-2088: risk of severe adverse events in juvenile idiopathic arthritis and pediatric-onset inflammatory bowel disease, treated with anti-tnf drugs
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044208/
http://dx.doi.org/10.1186/1546-0096-11-S2-P100
work_keys_str_mv AT vattap presfinal2088riskofsevereadverseeventsinjuvenileidiopathicarthritisandpediatriconsetinflammatoryboweldiseasetreatedwithantitnfdrugs
AT taddioa presfinal2088riskofsevereadverseeventsinjuvenileidiopathicarthritisandpediatriconsetinflammatoryboweldiseasetreatedwithantitnfdrugs
AT leporel presfinal2088riskofsevereadverseeventsinjuvenileidiopathicarthritisandpediatriconsetinflammatoryboweldiseasetreatedwithantitnfdrugs
AT moressav presfinal2088riskofsevereadverseeventsinjuvenileidiopathicarthritisandpediatriconsetinflammatoryboweldiseasetreatedwithantitnfdrugs
AT naviglios presfinal2088riskofsevereadverseeventsinjuvenileidiopathicarthritisandpediatriconsetinflammatoryboweldiseasetreatedwithantitnfdrugs
AT prinzie presfinal2088riskofsevereadverseeventsinjuvenileidiopathicarthritisandpediatriconsetinflammatoryboweldiseasetreatedwithantitnfdrugs

Ejemplares similares